CHES

International forum highlights the transformative power of lifestyle medicine to treat chronic disease and redefine health care

Retrieved on: 
Wednesday, February 28, 2024
Education, Death, Society, Non-communicable disease, CHES, American College, The Institute, Certification, WHO, IPH, Notifiable disease, International Board, Pharmacist, FACPM, Physician, Dentist, Weill Cornell Medicine, ACLM, CHWC, United Nations, Nursing, MPH, Knowledge, UN, LMGA, Human, Master of Science, United, CWP, Population health, Cancer, Public health, World Health Organization, Medicine, Pharmaceutical industry

ST. LOUIS, Feb. 28, 2024 /PRNewswire-PRWeb/ -- More than two dozen international experts in lifestyle medicine from 21 countries converged recently in Qatar at a forum to advocate for the growing medical specialty as an effective approach to treating noncommunicable chronic disease and transforming health worldwide.

Key Points: 
  • The Feb. 17 event, "Lifestyle Medicine - Redefining Healthcare to Promote Wellbeing," was organized by The Institute for Population Health (IPH) of Weill Cornell Medicine-Qatar, the Lifestyle Medicine Global Alliance (LMGA), and the International Board of Lifestyle Medicine (IBLM).
  • The forum was designed for physicians and other health professionals, including nurses, public health professionals, dentists, pharmacists, health care administrators, researchers and educators to develop the knowledge to discuss the growing field of lifestyle medicine and its opportunities, advancement and challenges.
  • Since certification in lifestyle medicine began in 2017, nearly 6,700 physicians and other health professionals have earned certification globally.
  • Ravinder Mamtani, MD, MSc, FACPM, FACOEM, DipABLM, vice dean for Population Health and Lifestyle Medicine, Weill Cornell Medicine – Qatar, and Sivaneswaran Poobalasingam, MD, DipIBLM, president of the Malaysian Society of Lifestyle Medicine, said the forum reinforced their belief that lifestyle medicine is "the way forward" for health care.

The Nation's Largest Black Maternal Health Conference Announces Speaker Lineup and an Award-Winning Film Premiere

Retrieved on: 
Tuesday, February 20, 2024
Bias, Woman, Fertility, Black women, CHES, Head, Policy, MPH, Maternal health, Medicine, Nursing

BOSTON, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Organizers of the 7th Annual Black Maternal Health Conference, the nation's largest convening focused on global Black maternal health outcomes, with nearly 4000 attendees annually, today announced its list of speakers for the April 5 full-day, virtual conference, and the newly added April 6 film premiere of Black Motherhood Through the Lens by filmmaker/producer Dr. Adeiyewunmi (Ade) Osinubi. Hosted by the Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine, the 7th Annual Black Maternal Health Conference centers on the role of technology in addressing Black maternal health disparities while creating a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.

Key Points: 
  • Ahead of Black Maternal Health Week, The 7th Annual Black Maternal Health Conference to Host Tech Experts and Premiere Black Motherhood Through the Lens Documentary
    BOSTON, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Organizers of the 7th Annual Black Maternal Health Conference , the nation's largest convening focused on global Black maternal health outcomes, with nearly 4000 attendees annually, today announced its list of speakers for the April 5 full-day, virtual conference, and the newly added April 6 film premiere of Black Motherhood Through the Lens by filmmaker/producer Dr. Adeiyewunmi (Ade) Osinubi.
  • Hosted by the Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine , the 7th Annual Black Maternal Health Conference centers on the role of technology in addressing Black maternal health disparities while creating a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.
  • The goal of the annual conference is to:
    Identify how health professionals can improve the Black maternal health experience.
  • Discounted early bird registration for the 7th Annual Black Maternal Health Conference is open, with the premiere included virtually for all registrants.

NACDD Announces Impact Award Winners and New Board of Directors

Retrieved on: 
Friday, September 29, 2023
BLS, CD, Washington State Department of Labor and Industries, Rising Star Award, Doctor of Public Health, Massachusetts Department of Public Health, Arkansas Department of Health, MSN, Maryland Department of Commerce, Ojamaa, Public, Bureau, Health promotion, Health equity, FNP, Performing arts of Australia, Utah Department of Health, TIME100 Impact Awards, New York State Department of Health, CHES, RDN, Doctor of Philosophy, NCD, DNP, MHS, FAAFP, -elect, Public health, Large, Non-communicable disease, Division, Maryland Department of Health, Family nurse practitioner, Chronic condition, Control, National Association, MPH, Washington State Department of Health, Community health, Pharmaceutical industry, Management, Nursing, MD

ATLANTA, Sept. 29, 2023 /PRNewswire/ -- The National Association of Chronic Disease Directors (NACDD) announced the winners of the 2023 Impact Awards as well as its new Board of Directors during the Annual Business Meeting held Sept. 26.

Key Points: 
  • ATLANTA, Sept. 29, 2023 /PRNewswire/ -- The National Association of Chronic Disease Directors (NACDD) announced the winners of the 2023 Impact Awards as well as its new Board of Directors during the Annual Business Meeting held Sept. 26.
  • The Impact Awards are nominated by NACDD Members and selected by a committee who evaluate the applications to identify the greatest impact on chronic disease prevention and control and health promotion.
  • "The passion, dedication, and innovation shown by NACDD Members across our states and territories is truly inspiring!
  • The newly elected At Large Directors are:
    Victoria Ballares, MSN, DNP, FNP, BLS, a board certified Family Nurse Practitioner in Guam.

U.S. FDA Approves AKEEGA™ (Niraparib and Abiraterone Acetate), the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer

Retrieved on: 
Friday, August 11, 2023
DSM-IV codes, Janssen Pharmaceuticals, Neoplasm, AE, Prostate cancer, Abiraterone acetate, CI, Drug, Constipation, BC Cancer Agency, Janssen, Prognosis, Mutation, AAP, RPF, CHES, ZERO, Science, Hypertension, Prednisone, Death, TCC, Patient, Hazard, TSP, Medicine, Cancer, HR, Genetic testing, Nausea, IA2, Johnson & Johnson, BRCA, FDA, PARP, Education, Disease, Safety, Fatigue, Pharmaceutical industry, Medical imaging, HORSHAM

HORSHAM, Pa., Aug. 11, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food & Drug Administration (FDA) has approved AKEEGA™ (niraparib and abiraterone acetate), the first-and-only dual action tablet combining a PARP inhibitor with abiraterone acetate, given with prednisone, for the treatment of adult patients with deleterious or suspected deleterious BRCA-positive mCRPC, as detected by an FDA-approved test.1

Key Points: 
  • *, Medical Oncologist at BC Cancer – Vancouver and principal investigator of the Phase 3 MAGNITUDE study.
  • "All individuals diagnosed with prostate cancer should consider genetic testing, especially those from racial and ethnic minority groups who tend to have worse cancer outcomes.
  • This is imperative to close the racial and ethnic disparities in prostate cancer health outcomes."
  • "This milestone, which marks the approval of Janssen's third prostate cancer treatment, highlights the importance of advancing precision medicine approaches and genetic testing for the treatment of patients with BRCA-positive mCRPC."

Leaders in Higher Education Join Advisory Panel Dedicated to Young Men's Personal Development with MANUAL

Retrieved on: 
Tuesday, June 27, 2023
Elmhurst University, Fraud Advisory Panel, Executive, Clark Atlanta University, University, Virgin Islands, Education, CHWC, University of the Virgin Islands, Suicide, University of Massachusetts Lowell, Health, CHES, Indiana University–Purdue University Indianapolis, Organization, Samford University, East Tennessee State University, Drug, Knowledge, Longevity, Research, MANUAL, MPH, Assistant director, Western Washington University, Morgan State University, Nursing, Management, Greek life

WASHINGTON, June 27, 2023 /PRNewswire/ -- MANUAL, an innovative, digital-first young men's personal development and mental health platform, announced the launch of its "Men's Outcomes in Higher Education Advisory Panel." The group is focused on increasing the retention of young men in college while reducing adverse mental health events, like suicide and overdose. The group is comprised of experienced scholars and thought leaders who will provide invaluable insights and guidance to shape MANUAL's resources and programs to inspire young men to become their best selves.

Key Points: 
  • WASHINGTON, June 27, 2023 /PRNewswire/ -- MANUAL, an innovative, digital-first young men's personal development and mental health platform, announced the launch of its "Men's Outcomes in Higher Education Advisory Panel."
  • The group is focused on increasing the retention of young men in college while reducing adverse mental health events, like suicide and overdose.
  • "We are honored to have an exceptional group of individuals join this Advisory Panel," said Matthew Stefanko, MANUAL's founder and CEO.
  • Through collaboration with the Advisory Panel, MANUAL aims to enhance its existing content and develop new resources that address the unique challenges young men face today.

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA® (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Retrieved on: 
Tuesday, May 30, 2023
Science, Radiology, Biotechnology, Research, Oncology, Health, FDA, Clinical Trials, Blood pressure, CT, Disease, Emory University School of Medicine, Prostate cancer, Diarrhea, 18F, Associate professor, Winship Cancer Institute, ZERO, PSMA, Food, Food and Drug Administration, Hope, PET, Multimedia, RH, CHES, Radiopharmaceutical, Cell, Prostate, Google Images, MS, MD Anderson Cancer Center, MRI, MD, Patient, Physician, Risk, Division, University, PET/CT, Diagnosis, Recurrence, PSA, Metastasis, Safety, Medical imaging

It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Key Points: 
  • It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.
  • “This event marks a major milestone in the expansion of Blue Earth Diagnostics’ robust prostate cancer portfolio.
  • POSLUMA was developed to assist physicians in the detection and localization of prostate cancer.
  • This new approval will, ultimately, give more options – and hope – to people impacted by prostate cancer.”

Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research, 4-Day Webinar Series Hosted by Xtalks

Retrieved on: 
Tuesday, March 7, 2023
Horizon Therapeutics, FSR, Health care, ICON PLC, Veronica, Partner (business rank), CHES, In-product communication, MD, MBA, Sarcoidosis, Senior, Janssen Pharmaceuticals, Disease, Enrollment, Decentralized Trials & Research Alliance, Bristol Myers Squibb, Entrepreneurship, College, Research, AVP Research Foundation, MPH, Rutgers University, Commercialization, Chairperson, IBD, Doctor of Philosophy, DCTS, Host, Patient advocacy, Gallaudet University, DAWN, Real Time Information Group, ICON, DEI, Bachelor of Science, Public affairs, Zwanzig projection operator, Nursing, Pharmaceutical industry, Birth control, Management, Honours degree, The Swift Home Service Club, Neuromuscular junction

TORONTO, March 7, 2023 /PRNewswire-PRWeb/ -- Each panel in this 4-day webinar series, whether watched individually or in totality with the other panels, will provide insights into the value of accessibility in rare disease clinical research and how sponsors, patient advocates, researchers and regulators might move from discussion to action.

Key Points: 
  • In this free webinar series, learn about myriad types of accessibility considerations for rare disease clinical research.
  • Attendees will learn how accessibility considerations fit into diversity, equity, and inclusion (DEI) plans.
  • The featured speakers will discuss best practices in accessible clinical trial design and implementation.
  • Panel 1: Is Disability Part of Your DEI Planning and Engagement in Rare Disease?

HEALTHCARE AND TECH LEADERS COME TOGETHER TO ARCHITECT A BETTER PATIENT PORTRAIT AT THE 2022 HIT CONFERENCE

Retrieved on: 
Monday, November 7, 2022
Population health, CHES, Challenge, Winter Olympic Games, BYU, Student, MS, Mother, Nationwide, ONC, AWS, Social determinants of health, Heart rate, Aligning Forces for Quality, Office of the National Coordinator for Health Information Technology, Patient, University, Deer Creek State Park (Utah), Amazon Web Services, Utah Department of Health, Office of Inspector General, U.S. Department of Health and Human Services, Accuro Healthcare Solutions, Concussion, Olympic Games, POTS, Bureau of Medical Services (U.S. Department of State), JPMorgan Chase, Frances Cox Henderson, The Challenge, Lunch, Technology, PyeongChang Organizing Committee for the 2018 Olympic & Paralympic Winter Games, State government, United States national team, Department, Uranium, Management, Health insurance, Medical device, Health care, Health, Olympic

SALT LAKE CITY, Nov. 7, 2022 /PRNewswire/ -- UHIN, leaders in healthcare interoperability, will host the 2022 HIT (Health Information Technology) conference on Thursday, Nov. 10 at the Salt Lake Marriott Downtown. The conference will convene professionals across healthcare and information technology to "Architect a Better Patient Portrait."

Key Points: 
  • $70 general admission tickets include access to all tracks and sessions, the exhibitor hall, lunch, and free parking.
  • To register, contact Scott Hazleton, Marketing Director, [email protected]
    Rich Saunders will open the conference with a welcome keynote address.
  • Healthcare Landscape track sessions and speakers - Focus on healthcare, technology and leadership topics on national and regional levels.
  • UHIN focuses on creating electronic exchange solutions that work for the entire healthcare community, from single-provider practices to large integrated healthcare systems.

Addiction Professionals of North Carolina Appoints New CEO

Retrieved on: 
Wednesday, October 19, 2022
Flo, Mental health, Culture, Growth, MS, Prior authorization, MFA, Organization, The Dr. Oz Show, MBA, APNC, Parity, Addiction, CHES, Board, Association, CEO, Howe, Travel, Communication, Member, Leadership, Management

RALEIGH, N.C., Oct. 19, 2022 /PRNewswire/ --Addiction Professionals of North Carolina (APNC) announces the appointment of Sara Moscato Howe, MBA, MS, CHES, as CEO, a position she will hold alongside her current leadership role with Third Horizon Strategies.

Key Points: 
  • RALEIGH, N.C., Oct. 19, 2022 /PRNewswire/ --Addiction Professionals of North Carolina (APNC) announces the appointment of Sara Moscato Howe, MBA, MS, CHES, as CEO, a position she will hold alongside her current leadership role with Third Horizon Strategies.
  • Ms. Howe will lead APNC remotely from Illinois with frequent travel to North Carolina.
  • As IABH CEO, Ms. Howe spearheaded strategic negotiations for Illinois' Emergency Opioid and Addiction Treatment Access Act, resulting in the removal of Prior Authorizations from addiction treatment services.
  • Addiction Professionals of North Carolina is the only North Carolina professional membership organization with a legislative voice that advocates exclusively on behalf of addiction professionals, organizations, and the communities they serve.

Fresno City Council Members and Safety Advocates Come Together to Oppose Dangerously Flawed California SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Wednesday, August 10, 2022
Fresno City Council, Multimedia, City, Drinking, Public health, Centers for Disease Control and Prevention, SB, STOP, Policy, Sale, District, Los Angeles City Council District 5, Fresno City Hall, Fresno Police Department, CDC, Center, DUI, Alcohol Justice, Safety, Assembly, Council, ACTION, Public policy, NO, Democratic Party, Health, CHES, Nightclub, Cathedral city (disambiguation)

FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.

Key Points: 
  • FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.
  • The experiment would take place in 6 cities: San Francisco, Oakland, West Hollywood, Cathedral City, Coachella, and Palm Springs.
  • "The effort to keep Fresno bars open until 4 a.m. from 2 a.m. was reckless and dangerous,"said Fresno City Councilmember Gary Bredefeld.
  • That's why several Council colleagues and I are bringing forward a Council resolution on August 11th opposing this stupidity.